Prelude Therapeutics Incorporated PRLD
$5.67
+2.16%
at last close
Financials (TTM)
- Revenue
- $22.42 million
- Net Income
- $-60,488,000
- Net Margin
- -269.75%
- Return on Equity
- -45.23%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 3.31
- Price / Sales
- 19.75
Over the trailing twelve months, Prelude Therapeutics Incorporated generated revenue of $22.42 million and net income of $-60,488,000, a net margin of -269.75%.
At the last closing price of $5.67, PRLD trades at 19.75 times sales, with a market capitalization of $442.91 million.
Key Stats
- Last Close
- $5.67
- Market Cap
- $442.91 million
- 52-Week Range
- $0.75 – $5.91
- Average Volume
- 371K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.